Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.

Vokes, E E; Panje, W R; Schilsky, R L; Mick, R; Awan, A M; Moran, W J; Goldman, M D; Tybor, A G; Weichselbaum, R R

Vokes, E E; Panje, W R; Schilsky, R L; Mick, R; Awan, A M; Moran, W J; Goldman, M D; Tybor, A G; Weichselbaum, R R.

Affiliation

Vokes EE; Department of Medicine, University of Chicago, Michael Reese Hospital Medical Centers, IL.

J Clin Oncol ; 7(6): 761-8, 1989 Jun.

Article in En | MEDLINE | ID: mdl-2715806

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Carcinoma/drug therapy; Fluorouracil/administration & dosage; Head and Neck Neoplasms/drug therapy; Hydroxyurea/administration & dosage; Adult; Aged; Aged, 80 and over; Bone Marrow/drug effects; Carcinoma/radiotherapy; Carcinoma, Squamous Cell/radiotherapy; Combined Modality Therapy; Drug Evaluation; Female; Fluorouracil/adverse effects; Follow-Up Studies; Head and Neck Neoplasms/radiotherapy; Humans; Hydroxyurea/adverse effects; Male; Middle Aged; Prognosis; Stomatitis/etiology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma / Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Fluorouracil / Head and Neck Neoplasms / Hydroxyurea Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 1989 Type: Article

Search on Google

XML

PubMed Links